A new trading day began on Tuesday, with Heron Therapeutics Inc (NASDAQ: HRTX) stock price up 3.05% from the previous day of trading, before settling in for the closing price of $1.31. HRTX’s price has ranged from $1.00 to $2.68 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 48.68% over the past five years. Meanwhile, its annual earnings per share averaged -11.11%. With a float of $181.64 million, this company’s outstanding shares have now reached $183.32 million.
Heron Therapeutics Inc (HRTX) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Heron Therapeutics Inc is 0.94%, while institutional ownership is 83.72%. The most recent insider transaction that took place on Aug 08 ’25, was worth 3,580,838. In this transaction 10% Owner of this company bought 2,387,225 shares at a rate of $1.50, taking the stock ownership to the 29,100,728 shares. Before that another transaction happened on Aug 08 ’25, when Company’s Director bought 1,766,546 for $1.50, making the entire transaction worth $2,649,819. This insider now owns 8,753,290 shares in total.
Heron Therapeutics Inc (HRTX) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of 0.02 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months).
According to the Wall Street analysts, stocks earnings will be around -11.11% per share during the next fiscal year.
Heron Therapeutics Inc (NASDAQ: HRTX) Trading Performance Indicators
Here are Heron Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.78. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.60.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.08, a number that is poised to hit -0.02 in the next quarter and is forecasted to reach 0.00 in one year’s time.
Technical Analysis of Heron Therapeutics Inc (HRTX)
Heron Therapeutics Inc (NASDAQ: HRTX) saw its 5-day average volume 1.32 million, a negative change from its year-to-date volume of 1.73 million. As of the previous 9 days, the stock’s Stochastic %D was 63.46%.
During the past 100 days, Heron Therapeutics Inc’s (HRTX) raw stochastic average was set at 74.47%, which indicates a significant increase from 70.67% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0828 in the past 14 days, which was higher than the 0.0740 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.2137, while its 200-day Moving Average is $1.6587. Nevertheless, the first resistance level for the watch stands at $1.3967 in the near term. At $1.4433, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.4967. If the price goes on to break the first support level at $1.2967, it is likely to go to the next support level at $1.2433. The third support level lies at $1.1967 if the price breaches the second support level.
Heron Therapeutics Inc (NASDAQ: HRTX) Key Stats
With a market capitalization of 247.53 million, the company has a total of 183,363K Shares Outstanding. Currently, annual sales are 144,290 K while annual income is -13,580 K. The company’s previous quarter sales were 38,210 K while its latest quarter income was -17,500 K.
